Revance Therapeutics Inc. sell WatchMen
Start price
20.05.24
/
50%
€2.86
Target price
31.03.25
€6.00
Performance (%)
-9.79%
Price
08.07.24
€2.58
Summary
This prediction is currently active. With a performance of -9.79%, the SELL prediction for Revance Therapeutics Inc. by WatchMen is down slightly. This prediction currently runs until 31.03.25. The prediction end date can be changed by WatchMen at any time. WatchMen has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Revance Therapeutics Inc. | - | - |
iShares Core DAX® | 0.786% | -0.427% |
iShares Nasdaq 100 | 2.297% | 7.331% |
iShares Nikkei 225® | 3.076% | 3.279% |
iShares S&P 500 | 0.902% | 3.970% |
Comments by WatchMen for this prediction
In the thread Revance Therapeutics Inc. diskutieren
Sell mit Kursziel 6,0
Stopped prediction by WatchMen for Revance Therapeutics Inc.
Revance Therapeutics Inc.
Start price
Target price
Perf. (%)
€4.18
31.03.24
31.03.24
€6.00
31.03.25
31.03.25
-31.58%
20.05.24
20.05.24